Search results
Results from the WOW.Com Content Network
The Biomedical Advanced Research and Development Authority (BARDA) is a U.S. Department of Health and Human Services (HHS) office responsible for the procurement and development of medical countermeasures, principally against bioterrorism, including chemical, biological, radiological and nuclear (CBRN) threats, as well as pandemic influenza and emerging diseases.
Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense (JPEO-CBRND) [1] is a sub-office of the ASA(ALT).. The Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense is the Joint Service’s lead for development, acquisition, fielding and life-cycle support of chemical, biological, radiological and nuclear defense equipment ...
The Chemical Biological Incident Response Force (CBIRF) is a Marine Corps unit responsible for countering the effects of a chemical, biological, radiological, nuclear, or high-yield explosive (CBRNE) incident, support counter CBRN terrorism, and urban search and rescue when CBRN incident.
It is the central education facility for medical training in the Bundeswehr and in charge of the coordination for military medicine and medical CBRN defense. Subordinate to the academy are three institutes for radiobiology , [ 1 ] microbiology [ 2 ] and for pharmacology / toxicology .
As a critical national asset in the CB defense community, CBC supports all phases of the acquisition life-cycle ― from basic and applied research through technology development, engineering design, equipment evaluation, product support, sustainment, field operations and demilitarization ― to address its customers’ unique requirements. [2]
CBRN incidents are responded to under the assumption that they are intentional and malicious; evidence preservation and perpetrator apprehension are of greater concern than with Hazmat team incidents. A 2011 forecast concluded that worldwide government spending on CBRN defense products and services would reach US$8.38 billion that year. [1]
Fourteen of 25 analysts following the stock have a “buy” or “strong buy” rating on L3Harris stock, with an average price target of $274.27. Pros and Cons of Defense Stocks
Pages in category "Chemical, biological, radiological and nuclear defense" The following 11 pages are in this category, out of 11 total. This list may not reflect recent changes .